N
SGFY

Natixis’s Signify Health, Inc. SGFY Stock Holding History

Natixis’s Portfolio SGFY Stock Details SGFY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-765,477
Closed -$21.9M – 1250
2022
Q4 		$21.9M Buy
765,477
+322,177
+73% +$9.3M 0.12% 155
2022
Q3 		$12.9M Buy
443,300
+366,536
+477% +$8.44M 0.06% 235
2022
Q2 		$1.08M Buy
+76,764
New +$1.08M ﹤0.01% 811

Other funds holding SGFY

BHCM
Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
FCA
FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Natixis's SGFY Position: Q1 2023 in Review

Natixis sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 765,477 shares — an estimated $21.9M sold.

Natixis first reported a position in SGFY in Q2 2022 and held it in 3 quarters. The position peaked at $21.9M in Q4 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

  • Natixis reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • Natixis sold 765,477 Signify Health, Inc. shares in Q1 2023, an estimated $21.9M.
  • Natixis first reported a position in Signify Health, Inc. in Q2 2022 and held it in 3 quarters.
  • Natixis's Signify Health, Inc. position peaked at $21.9M in Q4 2022.
  • 5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Natixis's 13F filing for Q1 2023, filed 12 May 2023.